Slingshot Insights | Cyad Overview

CYAD Overview

Upcoming Projects (CYAD)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (CYAD)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (CYAD)

Phase 1 data of Celyad's (CYAD) CYAD-101 (alloSHRINK) in Colorectal cancer to be presented at ESMO
Ticker: CYAD
Occurred on: Jul 05, 2019
Celyad(CYAD) initiates Phase 1 SHRINK and LINK trials of CYAD-01 in colorectal cancer patients diagnosed with unresectable liver metastases
Ticker: CYAD
Occurred on: May 03, 2018
Celyad (CYAD) Posts Phase 1 Dose-Escalation Data Evaluating NKG2D CAR-T Cells in Patients with Acute Myeloid Leukemia (AML) or Multiple Myeloma for Presentation at the 58th American Society of Hematology (ASH) Annual Meeting on December 3-6
Ticker: CYAD
Occurred on: Dec 06, 2016
Leukemia Research presented at American Association for the Advancement of Science (AAAS) leads to boost for CAR-T developers
Tickers: BLUE, KITE, CLLS, ZIOP, JUNO, BLCM, CYAD, ADAP
Occurred on: Feb 16, 2016

Strategic Initiatives (CYAD)

Don’t see a strategic initiative related to the company you care about? Create your own!